Evidence map›Paper›PMID 36217189›Full record

ArticleMicrobial cell factories2022

Metabolic engineering enables Bacillus licheniformis to grow on the marine polysaccharide ulvan.

Theresa Dutschei, Marie-Katherin Zühlke, Norma Welsch, Tom Eisenack, Maximilian Hilkmann, Joris Krull, Carlo Stühle, Stefan Brott, Alexandra Dürwald, Lukas Reisky and 4 more

Open access · goldAbstract read
In one paragraph

Article in Microbial cell factories, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. AdvancingMicroorganisms · 2024
    Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 1 country.

Theresa DutscheiDepartment of Biotechnology & Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17487, Greifswald, Germany.
Marie-Katherin ZühlkeDepartment of Pharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, 17487, Greifswald, Germany.
Norma WelschDepartment of Pharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, 17487, Greifswald, Germany.
Tom EisenackDepartment of Pharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, 17487, Greifswald, Germany.
Maximilian HilkmannDepartment of Pharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, 17487, Greifswald, Germany.
Joris KrullInstitute of Marine Biotechnology e.V., 17489, Greifswald, Germany.
Carlo StühleDepartment of Biotechnology & Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17487, Greifswald, Germany.
Stefan BrottDepartment of Biotechnology & Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17487, Greifswald, Germany.
Alexandra DürwaldDepartment of Pharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, 17487, Greifswald, Germany.
Lukas ReiskyDepartment of Biotechnology & Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17487, Greifswald, Germany.
Jan-Hendrik HehemannInstitute of Marine Biotechnology e.V., 17489, Greifswald, Germany.
Dörte BecherDepartment of Microbial Proteomics, Institute for Microbiology, University of Greifswald, 17487, Greifswald, Germany.
Thomas SchwederDepartment of Pharmaceutical Biotechnology, Institute of Pharmacy, University of Greifswald, 17487, Greifswald, Germany. schweder@uni-greifswald.de.
Uwe T BornscheuerDepartment of Biotechnology & Enzyme Catalysis, Institute of Biochemistry, University of Greifswald, 17487, Greifswald, Germany. uwe.bornscheuer@uni-greifswald.de.
Universität Greifswald · DEInstitute of Marine Biotechnology · DEMax Planck Institute for Marine Microbiology · DE

Funding

Bundesministerium für Bildung und Forschung 03WIR2205A/CDeutsche Forschungsgemeinschaft BO 1862/17-2, HE 7217/2-2, SCHW 595/10-2
6 · The paper itself

Abstract

backgroundMarine algae are responsible for half of the global primary production, converting carbon dioxide into organic compounds like carbohydrates. Particularly in eutrophic waters, they can grow into massive algal blooms. This polysaccharide rich biomass represents a cheap and abundant renewable carbon source. In nature, the diverse group of polysaccharides is decomposed by highly specialized microbial catabolic systems. We elucidated the complete degradation pathway of the green algae-specific polysaccharide ulvan in previous studies using a toolbox of enzymes discovered in the marine flavobacterium Formosa agariphila and recombinantly expressed in Escherichia coli.

resultsIn this study we show that ulvan from algal biomass can be used as feedstock for a biotechnological production strain using recombinantly expressed carbohydrate-active enzymes. We demonstrate that Bacillus licheniformis is able to grow on ulvan-derived xylose-containing oligosaccharides. Comparative growth experiments with different ulvan hydrolysates and physiological proteogenomic analyses indicated that analogues of the F. agariphila ulvan lyase and an unsaturated β-glucuronylhydrolase are missing in B. licheniformis. We reveal that the heterologous expression of these two marine enzymes in B. licheniformis enables an efficient conversion of the algal polysaccharide ulvan as carbon and energy source.

conclusionOur data demonstrate the physiological capability of the industrially relevant bacterium B. licheniformis to grow on ulvan. We present a metabolic engineering strategy to enable ulvan-based biorefinery processes using this bacterial cell factory. With this study, we provide a stepping stone for the development of future bioprocesses with Bacillus using the abundant marine renewable carbon source ulvan.

Indexed as

Bacillus licheniformisCarbon DioxideMetabolic EngineeringOligosaccharidesPolysaccharidesXyloseCarbon DioxideOligosaccharidesPolysaccharidesulvanXyloseBacillus licheniformisBiorefinery processGreen algaeMarine polysaccharideUlvan

Identifiers

PMID36217189
PMCPMC9549685
OpenAlexW4303984933

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.